LUXEMBOURG
“The recruitment of our first patients here in Luxembourg is a significant milestone, which will pave the way for the successful inclusion of all future participants across our three disease areas.”
The Luxembourg arm of the Clinnova project is led by the Luxembourg Institute of Health (LIH), in partnership with the University of Luxembourg, the Centre Hospitalier du Luxembourg (CHL) and Hôpitaux Robert Schuman.
The project is part of the FNR‘s (Luxembourg National Research Fund) National Centres of Excellence in Research (NCER), a programme providing a framework and funding instrument to bundle research excellence around a mission of significant societal relevance by encouraging high-level transdisciplinary research and inter-sectoral collaboration.
Partners
Funding Support
National Leadership
Dr. Jasmin
Schulz
Schulz
Dr. Maximilian
Fünfgeld
Fünfgeld
Dr. Christelle
Bahlawane
Bahlawane
Dr. Venkata
Satagopam
Satagopam
Dr. Marco
Hirsch
Hirsch
Data Architecture & Analysis
Dr. Maximilian
Fünfgeld
Fünfgeld
Dr. Michael
Schnell
Schnell
Dr. Venkata
Satagopam
Satagopam
Dr. Enrico
Glaab
Glaab
Directors’ Board
Prof. Simone
Niclou
Niclou
Dr. Martine
Goergen
Goergen
Prof. Marc
Berna
Berna
Dr. Ian
Tewes
Tewes
Bert
Verdonck
Verdonck
Related News
-
20 Feb 2026First Patient Enrolled in the Clinnova IBD Use Case at the Basel Site
-
10 Feb 2026Clinnova completes Phase 1 and becomes a cornerstone of Luxembourg’s national patient-centric research infrastructure
-
08 Jan 2026Clinnova – Ms Basel reaches one year follow-up milestone
-
28 Oct 2025Clinnova Consortium Meeting 2025: Where Collaboration Meets Vision
-
07 Oct 2025Clinnova Report Basel 2024–2025 is Live!
-
03 Oct 2025Clinnova Consortium Meeting 2025